134 related articles for article (PubMed ID: 22809428)
21. Multivariate analysis of the prognosis of 37 chondrosarcoma patients.
Yang ZM; Tao HM; Ye ZM; Li WX; Lin N; Yang DS
Asian Pac J Cancer Prev; 2012; 13(4):1171-6. PubMed ID: 22799300
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of Aurora B is associated with poor prognosis in epithelial ovarian cancer patients.
Chen YJ; Chen CM; Twu NF; Yen MS; Lai CR; Wu HH; Wang PH; Yuan CC
Virchows Arch; 2009 Nov; 455(5):431-40. PubMed ID: 19838728
[TBL] [Abstract][Full Text] [Related]
23. Aurora-A/STK-15 is a predictive factor for recurrent behaviour in non-invasive bladder carcinoma: a study of 128 cases of non-invasive neoplasms.
Compérat E; Camparo P; Haus R; Chartier-Kastler E; Radenen B; Richard F; Capron F; Paradis V
Virchows Arch; 2007 Apr; 450(4):419-24. PubMed ID: 17333265
[TBL] [Abstract][Full Text] [Related]
24. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
25. Insights into the prognostic value of DJ-1 and MIB-1 in astrocytic tumors.
Abd El Atti RM; Abou Gabal HH; Osman WM; Saad AS
Diagn Pathol; 2013 Jul; 8():126. PubMed ID: 23902708
[TBL] [Abstract][Full Text] [Related]
26. Aurora kinase inhibition overcomes cetuximab resistance in squamous cell cancer of the head and neck.
Hoellein A; Pickhard A; von Keitz F; Schoeffmann S; Piontek G; Rudelius M; Baumgart A; Wagenpfeil S; Peschel C; Dechow T; Bier H; Keller U
Oncotarget; 2011 Aug; 2(8):599-609. PubMed ID: 21865609
[TBL] [Abstract][Full Text] [Related]
27. Aurora B expression as a prognostic indicator and possible therapeutic target in oral squamous cell carcinoma.
Pannone G; Hindi SA; Santoro A; Sanguedolce F; Rubini C; Cincione RI; De Maria S; Tortorella S; Rocchetti R; Cagiano S; Pedicillo C; Serpico R; Lo Muzio L; Bufo P
Int J Immunopathol Pharmacol; 2011; 24(1):79-88. PubMed ID: 21496390
[TBL] [Abstract][Full Text] [Related]
28. Expression of mitotic kinases phospho-aurora A and aurora B correlates with clinical and pathological parameters in bladder neoplasms.
Bufo P; Sanguedolce F; Tortorella S; Cormio L; Carrieri G; Pannone G
Histol Histopathol; 2010 Nov; 25(11):1371-7. PubMed ID: 20865660
[TBL] [Abstract][Full Text] [Related]
29. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.
Xu Z; Liu Y; Yang Y; Wang J; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J
Oncotarget; 2017 Jan; 8(5):7548-7558. PubMed ID: 27911274
[TBL] [Abstract][Full Text] [Related]
30. A comprehensive analysis of Aurora A; transcript levels are the most reliable in association with proliferation and prognosis in breast cancer.
Yamamoto S; Yamamoto-Ibusuki M; Yamamoto Y; Fujiwara S; Iwase H
BMC Cancer; 2013 Apr; 13():217. PubMed ID: 23627634
[TBL] [Abstract][Full Text] [Related]
31. Gadd45β expression in chondrosarcoma: a pilot study for diagnostic and biological implications in histological grading.
Zenmyo M; Tanimoto A; Sakakima H; Yokouchi M; Nagano S; Yamamoto T; Ishido Y; Komiya S; Ijiri K
Diagn Pathol; 2010 Oct; 5():69. PubMed ID: 20942912
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of cathepsin B and urokinase plasminogen activator is associated with increased risk of recurrence and metastasis in patients with chondrosarcoma.
Häckel CG; Krueger S; Grote HJ; Oshiro Y; Hodges S; Johnston DA; Johnson ME; Roessner A; Ayala AG; Czerniak B
Cancer; 2000 Sep; 89(5):995-1003. PubMed ID: 10964329
[TBL] [Abstract][Full Text] [Related]
33. Lower cyclooxygenase-2 expression is associated with recurrence of solitary non-muscle invasive bladder carcinoma.
Tadin T; Krpina K; Stifter S; Babarović E; Fučkar Z; Jonjić N
Diagn Pathol; 2012 Nov; 7():152. PubMed ID: 23126361
[TBL] [Abstract][Full Text] [Related]
34. High aurora kinase expression identifies patients with muscle-invasive bladder cancer who have poor survival after neoadjuvant chemotherapy.
Burgess EF; Livasy C; Trufan S; Hartman A; Guerreri R; Naso C; Clark PE; Grigg C; Symanowski J; Raghavan D
Urol Oncol; 2019 Dec; 37(12):900-906. PubMed ID: 31597600
[TBL] [Abstract][Full Text] [Related]
35. Expression of SATB1 and HER2 in breast cancer and the correlations with clinicopathologic characteristics.
Liu X; Zheng Y; Qiao C; Qv F; Wang J; Ding B; Sun Y; Wang Y
Diagn Pathol; 2015 May; 10():50. PubMed ID: 25956130
[TBL] [Abstract][Full Text] [Related]
36. Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study.
dos Santos PB; Zanetti JS; Ribeiro-Silva A; Beltrão EI
Diagn Pathol; 2012 Aug; 7():104. PubMed ID: 22894137
[TBL] [Abstract][Full Text] [Related]
37. Identifying the Prognosis Factors and Predicting the Survival Probability in Patients with Non-Metastatic Chondrosarcoma from the SEER Database.
Huang R; Sun Z; Zheng H; Yan P; Hu P; Yin H; Zhang J; Meng T; Huang Z
Orthop Surg; 2019 Oct; 11(5):801-810. PubMed ID: 31663279
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma.
Li BK; Huang PZ; Qiu JL; Liao YD; Hong J; Yuan YF
Diagn Pathol; 2014 Dec; 9():226. PubMed ID: 25466449
[TBL] [Abstract][Full Text] [Related]
39. Aurora kinases as prognostic biomarkers in ovarian carcinoma.
Mendiola M; Barriuso J; Mariño-Enríquez A; Redondo A; Domínguez-Cáceres A; Hernández-Cortés G; Pérez-Fernández E; Sánchez-Navarro I; Vara JA; Suárez A; Espinosa E; González-Barón M; Palacios J; Hardisson D
Hum Pathol; 2009 May; 40(5):631-8. PubMed ID: 19157502
[TBL] [Abstract][Full Text] [Related]
40. Cyclooxygenase-2 expression in chondrosarcoma.
Sutton KM; Wright M; Fondren G; Towle CA; Mankin HJ
Oncology; 2004; 66(4):275-80. PubMed ID: 15218294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
